NIDC News

Our NIDC News reports the latest developments in U.S. Department of Energy’s isotope production efforts, university partnerships, facility improvements, staff news, and other notable center activities as they occur. Stay Connected

 

Actinium-225 DMF Accepted by the FDA
The DOE Isotope Program (DOE IP) is pleased to announce that the U.S. Food and Drug Administration (FDA) has accepted its Type II Drug Master File (DMF) submission for Actinium-225 Nitrate (Accelerator-Produced). The alpha-emitting radionuclide and its decay product bismuth-213 (Bi-213), from an Ac-225/Bi-213 generator, have gained considerable interest within the medical community for…
2020 Events Schedule for DOE IP
Hello 2020! As we embark on a new year and new decade, the DOE Isotope Program is ready to focus on a new year full of exciting events and opportunities to connect with all of you. With so much on the horizon, we have compiled a list of events we are attending and/or sessions where Isotope Program supported researchers are chairing or presenting. As we approach each event, more detailed…
NIDC Annual Customer Survey
The NIDC, on behalf of the DOE Isotope Program, seeks input from the community on anticipated isotope product needs and potential supply shortages in the next five years. With this valuable information, the DOE IP will gain a clearer understanding of future market demand and, as a result, can better serve industrial and research entities by tailoring isotope production to meet their expressed…
ACS National Meeting & Exposition Call for Abstracts - Open Now
The American Chemical Society Spring 2020 National Meeting & Expo will take place March 22–26 in Philadelphia, PA. The U.S. Department of Energy Isotope Program together with the University of California Berkeley and Los Alamos National Laboratory will chair an informational forum titled "Radiotherapeutics: From Isotope Production to Targeted Delivery" where …
Visit the Isotope Program at the European Associate on Nuclear Medicine (EANM)
Are you planning to attend the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona, Spain? If so, then stop by Booth #27, located at the entrance to the exhibit hall, to speak with our staff about your isotope needs and to find informational material on our latest products and services, R&D initiatives, and more. We look forward to seeing you in Barcelona!
 Stock photo of people in a meeting
Don't Miss Your Chance to Meet with the DOE Isotope Program The U.S. Department of Energy Isotope Program (DOE IP) has set aside Monday, October 28, and Tuesday, October 29, 2019, for "one-on-one" stakeholder meetings. These meetings offer a great opportunity for the isotope community to personally discuss isotope supply and demand issues with the DOE IP Director, DOE program managers, and the…
DOE Isotope Program Medical Isotope Production Video
Take a behind-the-scenes look at our production of medical isotopes, critical to providing diagnostic and therapeutic products for the medical community. View Video  
(From left) Rebecca Abergel, Abel Ricano, and Gauthier Deblonde of Berkeley Lab’s Chemical Sciences Division have pioneered a faster method of purifying elements. (Credit: Marilyn Chung/Berkeley Lab)
The actinides – those chemical elements on the bottom row of the periodic table – are used in applications ranging from medical treatments to space exploration to nuclear energy production. But purifying the target element so it can be used, by separating out contaminants and other elements, can be difficult and time-consuming. Now researchers at the Department of Energy’s Lawrence Berkeley…
Nuclide Chart
Recently the National Nuclear Data Center (NNDC), managed by the U.S. Department of Energy Office of Science for Nuclear Physics, updated the half-life value of actinium-225 (Ac-225) to 9.92 days. This is a change from the previously used value of 10.0 days. This update was made based on a paper published in Applied Radiation and Isotopes titled "Measurement of the Ac-225…
Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.
Recycled medical devices, diverted from going to a special landfill, supply the key ingredient in a drug that treats prostate cancer. Researchers at Oak Ridge National Laboratory have developed and demonstrated a process to produce actinium-227 using harvested radium-226 from legacy medical devices. The devices are secured by the Department of Energy Isotope Program. Scientists convert the…